The NLRP3 inflammasome pathway, a key target in depression, mediates the production of proinflammatory cytokines such as interleukin-1beta (IL-1beta) and interleukin-18 (IL-18) (Xu et al., 2016). Here, NLRP3 is linked to depressive symptom measurement.